Estrella Immunopharma- Warrants (29/09/2028) Other Current Liabilities

The latest other current liabilities for ESLAW is $9.2M as of June 2026. That compares with $9.1M in the prior-year period — up 2.0% year over year. Investors often review this figure alongside Estrella Immunopharma- Warrants (29/09/2028)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, ESLAW's other current liabilities moved from $9.1M to $9.2M — a 2.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Estrella Immunopharma- Warrants (29/09/2028)'s operating scale or balance-sheet position.

A other current liabilities figure of $9.2M for ESLAW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ESLAW's other current liabilities ($9.2M), review year-over-year change from $9.1M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.